Clinical Highlights From the American Diabetes Association's Scientific Sessions

Endocrinologist Robert Gabbay, MD, PhD, the ADA's chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, "game-changing" diabetes technologies, and a new use for a familiar drug. Related Content: New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA's Scientific Sessions

Episode metadata supplied by the publisher feed · Published Jul 26, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Clinical Highlights From the American Diabetes Association's Scientific Sessions

0:00 18:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Medical News?

This episode is 18 minutes long.

When was this JAMA Medical News episode published?

This episode was published on July 26, 2024.

Can I download this JAMA Medical News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!